Quality-of-life issues in patients with ductal carcinoma in situ

Journal of the National Cancer Institute - Monographs

Volumn , Issue 41, 2010, Pages 218-222

  Ganz, Patricia A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ANXIETY; ARTICLE; CALCIFICATION; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LIFE EXPECTANCY; LIFESTYLE; MAMMOGRAPHY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ATTITUDE TO HEALTH; BREAST TUMOR; COST OF ILLNESS; DISEASE COURSE; ECONOMICS; FEAR; MASTECTOMY; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SELF CONCEPT; STATISTICS;

ADULT; AGED; ANXIETY; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; COST OF ILLNESS; DISEASE PROGRESSION; FEAR; FEMALE; HUMANS; LIFE EXPECTANCY; MASTECTOMY; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SELF CONCEPT; STRESS, PSYCHOLOGICAL;

EID: 79952197093     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgq029     Document Type: Article

References (24)

1. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350(14):1430-1441.
2. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-1554.
3. Partridge A, Winer JP, Golshan M, et al. Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008;8(3):275-280.
4. Veronesi U, Zurrida S, Goldhirsch A, Rotmensz N, Viale G. Breast cancer classification: time for a change. J Clin Oncol. 2009;27(15):2427-2428.
5. De Morgan S, Redman S, White KJ, Cakir B, Boyages J. 'Well, have I got cancer or haven't I?' The psycho-social issues for women diagnosed with ductal carcinoma in situ. Health Expect. 2002;5(4):310-318.
6. Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med. 2001;10(6):589-598.
7. Amichetti M, Caffo O, Arcicasa M, et al. Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat. 1999;54(2):109-115.
8. Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77(3):285-293.
9. Casso D, Buist D, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes. 2004;2(1):25.
10. Janz NK, Mujahid M, Lantz PM, et al. Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res. 2005;14(6):1467-1479.
11. Nekhlyudov L, Kroenke CH, Jung I, Holmes MD, Colditz GA. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study. J Clin Oncol. 2006;24(18):2822-2827.
12. van Gestel YRBM, Voogd AC, Vingerhoets AJJM, et al. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer. 2007;43(3):549-556.
13. Janz NK, Mujahid M, Chung LK, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health. 2007;16(9):1348-1361.
14. Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243-251.
15. Lauzier S, Maunsell E, Levesque P, et al. Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer. Breast Cancer Res Treat. 2010;120(3):685-691.
16. Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006;295(23):2727-2741.
17. Land SR, Wickerham DL, Costantino JP, et al. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006;295(23):2742-2751.
18. Report of the Breast Cancer Progress Review Group. Charting the Course: Priorities for Breast Cancer Research. National Cancer Institute; 1998. http://planning.cancer.gov/library/1998breastcancer.pdf. Accessed August 17, 2010.
19. Board of Health Care Services, Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. National Academies Press; 2009. http://www.iom.edu/en/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx. Accessed December 20, 2009.
20. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008;168(21):2311-2316.
21. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
22. Thaler RH. Gauging the odds (and the costs) in health screening. New York Times. December 19, 2009. http://www.nytimes.com/2009/12/20/business/20view.html?_r=1&scp=7&sq=Thaler&st=nyt. Accessed December 20, 2009.
23. Thompson A, Brennan K, Cox A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10(2):R26.
24. Nekhlyudov L, Habel LA, Achacoso NS, et al. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009;27(19):3211-3216.